Characteristic | No. (%) of patients n = 10 881 | No. (%) of patients who received cancer-directed therapy n = 4144 | No. (%) of patients who received best supportive care n = 6737 | Standardized difference | p value |
---|---|---|---|---|---|
Age at diagnosis, yr | |||||
≤ 60 | 2318 (21.3) | 1380 (59.5) | 938 (40.5) | 0.47 | < 0.001 |
61–70 | 2743 (25.2) | 1358 (49.5) | 1385 (50.5) | 0.28 | |
71–80 | 3238 (29.8) | 1118 (34.5) | 2120 (65.5) | 0.1 | |
≥ 81 | 2582 (23.7) | 288 (11.1) | 2294 (88.8) | 0.71 | |
Female sex | 5450 (50.1) | 1906 (35.0) | 3544 (65.0) | 0.13 | < 0.001 |
Rural residence | 1595 (14.7) | 517 (32.4) | 1078 (67.6) | 0.1 | < 0.001 |
High comorbidity burden (ADG ≥ 10) | 3890 (35.8) | 1261 (32.4) | 2629 (67.6) | 0.18 | < 0.001 |
Income quintile | |||||
5th (highest) | 1973 (18.1) | 834 (42.2) | 1139 (57.7) | 0.08 | |
4th | 2138 (19.6) | 902 (42.2) | 1236 (57.8) | 0.09 | |
3rd | 2183 (20.1) | 861 (39.4) | 1322 (60.6) | 0.03 | |
2nd | 2274 (20.9) | 832 (36.5) | 1442 (63.4) | 0.03 | |
1st (lowest) | 2254 (20.7) | 715 (31.7) | 1598 (69.1) | 0.15 | < 0.001 |
Diagnosed in 2011–2016 | 5033 (46.3) | 2199 (43.7) | 2834 (56.3) | 0.22 | < 0.001 |
Note: ADG = Aggregated Diagnosis Group.